Cargando…

Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province

Background: The increasing incidence of breast cancer and its financial burden highlights the need for controlling treatment costs. This study aimed to assess the direct costs of inpatient and outpatient care for breast cancer patients in Liaoning Province to provide a policy reference for cost cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zihua, Deng, Gongman, Meng, Zhaolin, Ma, Yanan, Wu, Huazhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808230/
https://www.ncbi.nlm.nih.gov/pubmed/34380200
http://dx.doi.org/10.34172/ijhpm.2021.75
_version_ 1784862893824540672
author Ma, Zihua
Deng, Gongman
Meng, Zhaolin
Ma, Yanan
Wu, Huazhang
author_facet Ma, Zihua
Deng, Gongman
Meng, Zhaolin
Ma, Yanan
Wu, Huazhang
author_sort Ma, Zihua
collection PubMed
description Background: The increasing incidence of breast cancer and its financial burden highlights the need for controlling treatment costs. This study aimed to assess the direct costs of inpatient and outpatient care for breast cancer patients in Liaoning Province to provide a policy reference for cost containment. Methods: Based on the System of Health Accounts 2011 (SHA 2011), systematic data collection was conducted via multistage stratified cluster random sampling. A total of 1160 health institutions, including 83 hospitals, 16 public health institutions, 120 primary health institutions, and 941 outpatient institutions were enrolled in 2017. A database was established containing 20 035 patient-level medical records from the information system of these institutions. Curative care expenditure (CCE)was calculated, and generalized linear modeling was performed to determine cost-related factors. Results: In 2017, the CCE for breast cancer was approximately CNY 830.19 million (US$122.96 million) in Liaoning province (0.7% of the total health expenditure and 9.9% of cancer-related healthcare costs). Inpatient care costs were estimated to be CNY 617.27 million (US$91.42 million), accounting for 74.4% of the CCE for breast cancer, almost three times as large as outpatient costs (25.6%). The average inpatient and outpatient costs for breast cancer were estimated to be CNY 12 108 (US$1793) and CNY 829 (US$123) per visit. Medication cost was the main cost driver, which comprised 84.0% of the average outpatient cost and 37.2% of the mean inpatient cost. Conclusion: Breast cancer imposes a large economic burden on patients and the social health insurance system. Results show an irrational cost pattern of inpatient and outpatient services, with patients relying excessively on inpatient services for treatment. Promoting outpatient care whenever relevant is conducive to cost containment and rational utilization of resources.
format Online
Article
Text
id pubmed-9808230
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-98082302023-01-10 Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province Ma, Zihua Deng, Gongman Meng, Zhaolin Ma, Yanan Wu, Huazhang Int J Health Policy Manag Original Article Background: The increasing incidence of breast cancer and its financial burden highlights the need for controlling treatment costs. This study aimed to assess the direct costs of inpatient and outpatient care for breast cancer patients in Liaoning Province to provide a policy reference for cost containment. Methods: Based on the System of Health Accounts 2011 (SHA 2011), systematic data collection was conducted via multistage stratified cluster random sampling. A total of 1160 health institutions, including 83 hospitals, 16 public health institutions, 120 primary health institutions, and 941 outpatient institutions were enrolled in 2017. A database was established containing 20 035 patient-level medical records from the information system of these institutions. Curative care expenditure (CCE)was calculated, and generalized linear modeling was performed to determine cost-related factors. Results: In 2017, the CCE for breast cancer was approximately CNY 830.19 million (US$122.96 million) in Liaoning province (0.7% of the total health expenditure and 9.9% of cancer-related healthcare costs). Inpatient care costs were estimated to be CNY 617.27 million (US$91.42 million), accounting for 74.4% of the CCE for breast cancer, almost three times as large as outpatient costs (25.6%). The average inpatient and outpatient costs for breast cancer were estimated to be CNY 12 108 (US$1793) and CNY 829 (US$123) per visit. Medication cost was the main cost driver, which comprised 84.0% of the average outpatient cost and 37.2% of the mean inpatient cost. Conclusion: Breast cancer imposes a large economic burden on patients and the social health insurance system. Results show an irrational cost pattern of inpatient and outpatient services, with patients relying excessively on inpatient services for treatment. Promoting outpatient care whenever relevant is conducive to cost containment and rational utilization of resources. Kerman University of Medical Sciences 2021-08-01 /pmc/articles/PMC9808230/ /pubmed/34380200 http://dx.doi.org/10.34172/ijhpm.2021.75 Text en © 2022 The Author(s); Published by Kerman University of Medical Sciences https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ma, Zihua
Deng, Gongman
Meng, Zhaolin
Ma, Yanan
Wu, Huazhang
Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province
title Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province
title_full Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province
title_fullStr Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province
title_full_unstemmed Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province
title_short Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province
title_sort unbalanced treatment costs of breast cancer in china: implications from the direct costs of inpatient and outpatient care in liaoning province
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808230/
https://www.ncbi.nlm.nih.gov/pubmed/34380200
http://dx.doi.org/10.34172/ijhpm.2021.75
work_keys_str_mv AT mazihua unbalancedtreatmentcostsofbreastcancerinchinaimplicationsfromthedirectcostsofinpatientandoutpatientcareinliaoningprovince
AT denggongman unbalancedtreatmentcostsofbreastcancerinchinaimplicationsfromthedirectcostsofinpatientandoutpatientcareinliaoningprovince
AT mengzhaolin unbalancedtreatmentcostsofbreastcancerinchinaimplicationsfromthedirectcostsofinpatientandoutpatientcareinliaoningprovince
AT mayanan unbalancedtreatmentcostsofbreastcancerinchinaimplicationsfromthedirectcostsofinpatientandoutpatientcareinliaoningprovince
AT wuhuazhang unbalancedtreatmentcostsofbreastcancerinchinaimplicationsfromthedirectcostsofinpatientandoutpatientcareinliaoningprovince